| NCT06152042 | Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus | TERMINATED | PHASE2 | 2023-12-28 | 2025-07-18 | 2025-05-20 |
| NCT05918692 | A Phase 1, Study of BMF-500 in Adults With Acute Leukemia | RECRUITING | PHASE1 | 2023-07-26 | 2025-12-31 | 2025-07-31 |
| NCT05631574 | Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer | TERMINATED | PHASE1 | 2023-01-12 | 2025-01-15 | 2025-01-15 |
| NCT05731544 | Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D) | COMPLETED | PHASE1, PHASE2 | 2022-08-17 | 2025-07-08 | 2024-11-18 |
| NCT05153330 | Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL | TERMINATED | PHASE1 | 2022-01-24 | 2025-05-02 | 2025-02-13 |